Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faecal microbiota transplantation capsules for intestinal decolonisation of ESBL/CPE carriage
ISRCTN34467677Phase 2Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Sep 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
01
Overview
Phase 2, randomised, double-blind trial in Not applicable—colonization is not a disease, Enterobacterales colonization and Carbapenem-resistant Enterobacteriaceae colonization comparing FMT capsules with Placebo capsules (2 arms). Primary endpoint: Consent rate of eligible patients. Started Sep 2020; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Not applicable—colonization is not a diseaseEnterobacterales colonizationCarbapenem-resistant Enterobacteriaceae colonization
Beyond the preview
Go deeper on ISRCTN34467677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34467677.